Dermata Therapeutics, Inc.
DRMA
$1.21
-$0.02-1.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.98% | 38.00% | 38.49% | 21.50% | -5.22% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.81% | 39.22% | -78.15% | -80.96% | -85.32% |
| Change in Net Operating Assets | 124.09% | -241.18% | -173.44% | -157.14% | -162.93% |
| Cash from Operations | 26.68% | 20.10% | 30.51% | 0.58% | -41.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -52.77% | -60.12% | 83.00% | -4.12% | 199.89% |
| Repurchase of Common Stock | 97.84% | -708.21% | -708.21% | -78,587.50% | -1,603.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -568.72% | -80.99% | -- | -- | 127.86% |
| Cash from Financing | -51.35% | -64.05% | 75.97% | -11.75% | 193.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -234.83% | -155.64% | 201.96% | -203.38% | 143.93% |